The new Department of Labor fiduciary standard represents «the most dramatic
regulatory change in a number of decades, suffice to say,» explained Scott Curtis, head of Raymond James» independent advisor channel, in an interview on Tuesday.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the
number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive
regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to
changes in its stock price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
After digging deeper by looking at the April
numbers, which were impacted by
regulatory changes in China, the company instigated a trading halt on Friday.
A
number of factors could cause actual results or outcomes to differ materially from those indicated by such forward - looking statements, including but not limited to, (1) our ability to open new restaurants and food and beverage locations
in current and additional markets, grow and manage growth profitably, maintain relationships with suppliers and obtain adequate supply of products and retain our key employees; (2) factors beyond our control that affect the
number and timing of new restaurant openings, including weather conditions and factors under the control of landlords, contractors and
regulatory and / or licensing authorities; (3)
changes in applicable laws or regulations; (4) the possibility that the Company may be adversely affected by other economic, business, and / or competitive factors; and (5) other risks and uncertainties indicated from time to time
in our filings with the SEC, including our Annual Report on Form 10 - K filed on March 30, 2016 and our Quarterly Report on Form 10 - Q filed on August 15, 2016.
We also recognise that climate
change presents a
number of risks to our business, particularly
in relation to
regulatory changes and the impact of
changing climatic conditions on our vineyards.
Conditions The Scheme is subject to a
number of conditions including: • Coal & Allied shareholder approvals • no
regulatory action
in relation to the Scheme • receipt of
regulatory approvals • Foreign Investment Review Board approval • no material adverse
change occurring • no prescribed occurrences
In Nasonia, non-coding cis - regulatory evolution at the ws1 locus causes changes in both cell size and cell numbe
In Nasonia, non-coding cis -
regulatory evolution at the ws1 locus causes
changes in both cell size and cell numbe
in both cell size and cell
number.
And there are also a
number of federal laws that relate to student privacy, one of which is the 40 - year - old Family Educational Rights and Privacy Act (FERPA), which has undergone
regulatory changes in recent years that some claimed have weakened it.
Whether or not actual results and developments will conform to ProShare Advisors LLC's expectations and predictions, however, is subject to a
number of risks and uncertainties, including general economic, market and business conditions,
changes in laws or regulations or other actions made by governmental authorities or
regulatory bodies, and other world economic and political developments.
From page 4 of the study, a graph showing the decline
in the
number of IPOs and the timing of
regulatory changes:
Given that a
number of other animal control programs and
regulatory changes were implemented during the study period, separating out the effects of a single program may be impossible... Data were not collected on how many adoptable versus nonadoptable cats were impounded, so it was not possible specifically to assess
changes in outcomes for feral cats, only
changes in overall cat outcomes... it can be stated that the implementation of sterilization of feral cats as part of a TNR program did not result
in negative
changes.
The dynamic interplay of an increasing
number of users and uses,
in a context of political and
regulatory uncertainty and global environmental
changes, has catalysed stories of hope, hype and horror about the future of the Arctic.
Apologies for being potentially off - topic, but for those of you with an interest
in the legal aspects of climate
change and
regulatory policy, a
number of organizations are offering 8:30 am — 12 noon program on March 1 here
in Washington DC entitled «Debrief of the DC Circuit's Oral Arguments on EPA's GHG Rulemakings March 1, 2012» (http://www.facebook.com/events/370847879593650/).
Those
numbers are likely to
change given the modifications to the ITC
in the deal, but Einowski expects the extensions to help eliminate some of the
regulatory uncertainty surrounding renewable power.
This analytical document provides insights into the issues associated with 100 per cent renewable energy targets, as it is understood that over the next decades a
number of
changes are likely to occur
in technology, economics and
regulatory environment.
The
number of wage and hour lawsuits and U.S. Department of Labor investigations has increased exponentially
in recent years, spurred by actual and proposed legislative and
regulatory changes to the Fair Labor Standards Act (FLSA), as well as the evolving requirements of a growing workforce of independent contractors and other non-traditional employees.
If the
changes were to be implemented might we, for example, see one of our
number facing a
regulatory investigation and possible sanction because an aggrieved neighbour has complained to the SRA about an interaction with the individual solely
in the context of living
in the adjacent property, alleging that the professional's behaviour demonstrated a lack of integrity.
They are working on a
number of issues
in Alberta including some
regulatory litigation as well as
changes to market rules always
in other markets such as Texas.
A
number of the firm's labour lawyers specialize
in collective bargaining negotiations, while others have expertise
in government relations, including the process of legislative and
regulatory change.
Regardless of the
number of filings, Groshek believes ExactCare Extra went through the
regulatory process faster than the average policy
change, a fact that she attributed to her team's expertise
in the space.
The core essence of «trust» — created today with government guarantees, physical vaults, behemoth balance sheets to make institutions seemingly «too big to fail», and layer upon layer of
regulatory framework enforced by «zillions» (yes I know its not a real
number and not an accurate one, but there's no way for me to count the bodies spending time making banks function) of people leading very exciting lives holding a gigantic ball of water
in the air — is likely on the front edge of a very big wave of foundational
change.
In the 10 - K, AMD indicated that several factors could change the environment on the GPU front, highlighting market and regulatory risks that could lead to a decline in the number of GPUs being bought by cryptocurrency miner
In the 10 - K, AMD indicated that several factors could
change the environment on the GPU front, highlighting market and
regulatory risks that could lead to a decline
in the number of GPUs being bought by cryptocurrency miner
in the
number of GPUs being bought by cryptocurrency miners.
The new year brought a
number of
regulatory changes that impact the GSEs, FHA, VA, and the market
in general.
Let us also face the fact that the
number of
regulatory changes that occur
in a 2 year period are negligible.